ICMR: People who need #not be tested: 1. Asymptomatic individuals in community settings 2. Contacts of confirmed cases of #COVID19 unless identified as high risk based on age or co-morbidities 3. Patients who stand discharged as per home isolation guidelines
*FOLLOW THREAD*
ICMR: People who need #not be tested: 4. Patients being discharged from a COVID-19 facility as per revised discharge policy 5. Individuals undertaking inter-state domestic travel
*More in the thread*
Who may be tested:
A. In community settings: 1. Symptomatic (cough, fever, sore throat, loss of taste and/or smell, breathlessness and/or
other respiratory symptoms) individuals. 2. At-risk contacts of laboratory confirmed cases. {elderly (>60yr) & with co-morbidity}
Who may be tested:
A. In community settings: 3. Individuals undertaking international travel (as per country-specific requirements). 4. International travelers arriving at Indian airports/seaports/ports of entries as per laid down
guidelines.
Who may be tested:
B. In Hospital Settings: 5. Testing may be undertaken as per discretion of the treating doctor with the following
considerations:
No emergency procedure (including surgeries and deliveries) should be delayed for lack
of a test.
Who may be tested:
B. In Hospital Settings:
Patients should not be referred to other facilities for lack of a testing facility. All
arrangements should be made to collect and transfer samples to testing facilities,
mapped to the health facility.
Who may be tested In Hospital:
Asymptomatic patients undergoing surgical / non-surgical invasive procedures including
pregnant women in/near labour should not be tested unless warranted or symptoms develop.
Admitted patients may not be tested more than once a week.
#CNBCTV18Market | Credit Suisse on RBI Policy: As expected, MPC kept rates unchanged, tweaked growth/ inflation forecasts a bit. While stance remains 'accommodative', bulk of overnight surpluses has shifted to VRRR
#CNBCTV18Market | Citi maintains its view of limited upside, December 2022 Nifty target at 17,500. Says, post the big upgrade cycle in Q3/Q4, consensus estimates have been unchanged
#CNBCTV18Market | Citi on RBI Policy: It strongly reiterated its growth bias in policy as the omicron variant poses risks. Have pushed Normalisation’ trajectory further out into 2022